Clinical Trial: A-protein Levels in Adult and Pediatric Brain Tumor Patients
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Determination of A-Protein Levels in Adult and Pediatric Brain Tumor Patients
Brief Summary: The purpose of this study is to evaluate the sensitivity and specificity of "A-PROTEIN" levels in patients with brain tumors. A-PROTEIN levels will be analyzed both pre and post treatment. Levels in blood and/or cerebrospinal fluid (CSF) will be analyzed and correlated with the underlying diagnosis and outcome.
Detailed Summary:
- Patients will be identified at the time of presentation to their neurologist, neurosurgeon or oncologist.
- Blood or cerebrospinal fluid will be collected for this study only when they are being collected for other reasons before and after each surgery. Samples will also be collected after any event such as significant change in symptoms or radiographic progression.
- Once the patients condition has been stabilized, samples will be take at regular intervals of >= 1 month. The duration of this study is 24 months.
Sponsor: Dana-Farber Cancer Institute
Current Primary Outcome: association between serum A-Protein level class and clinical status [ Time Frame: 4 years ]
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Dana-Farber Cancer Institute
Dates:
Date Received: September 12, 2005
Date Started: June 1998
Date Completion:
Last Updated: November 21, 2016
Last Verified: November 2016